Medicare Coverage for Chronic Pain Management

Chronic pain affects more than 50% of adults over 65, making it one of the most common and costly conditions managed under Medicare. Whether the cause is arthritis, neuropathy, spinal disease, fibromyalgia, or post-surgical pain, Medicare covers a broad range of treatments — from physical therapy and pain psychology to interventional procedures and prescription medications.

Understanding which treatments fall under which part of Medicare, and what the cost-sharing looks like across different coverage options, helps chronic pain patients make informed decisions about both treatment and insurance coverage.

What Counts as Chronic Pain for Medicare Coverage

Medicare does not define a specific threshold for “chronic pain” eligibility. Coverage is based on medical necessity — whether the treating physician documents that a service is reasonable and necessary for the diagnosis or treatment of illness or injury. For chronic pain, this means:

• The diagnosis must be clearly documented in the medical record (ICD-10 codes for specific pain conditions)
• The treatment selected must be appropriate for the documented condition
• Documentation must justify continuation of treatment (for ongoing services like physical therapy)

Chronic pain from these common sources is well-established as medically necessary: lumbar degenerative disc disease, spinal stenosis, osteoarthritis, rheumatoid arthritis, peripheral neuropathy (including diabetic neuropathy), complex regional pain syndrome (CRPS), cancer pain, and post-herpetic neuralgia.

Physical Therapy for Chronic Pain Under Part B

Physical therapy is one of the most commonly used and cost-effective treatments for chronic musculoskeletal pain. Medicare covers outpatient physical therapy under Part B with important rules:

Cost-sharing: 20% coinsurance after the $257 annual Part B deductible (2025). If you have Medigap Plan G, this coinsurance is fully covered.

No hard annual visit cap: The therapy cap was permanently eliminated in 2018. However, once your combined physical therapy, occupational therapy, and speech-language pathology spending (in terms of Medicare reimbursement to the provider) exceeds $2,330 in a calendar year (2025 threshold), each claim requires a KX modifier from your therapist certifying that continued treatment is medically necessary. As long as progress or medical necessity is documented, therapy continues without a cap.

Maintenance therapy: Under the 2013 Jimmo v. Sebelius settlement, Medicare must cover maintenance therapy — therapy intended to prevent decline or maintain function, not just to achieve measurable improvement. This is particularly important for chronic pain patients who need ongoing PT to manage their condition rather than achieve a defined endpoint of recovery.

Occupational therapy for functional limitations caused by chronic pain (e.g., difficulty with activities of daily living due to severe arthritis) is covered under the same Part B terms.

Interventional Pain Procedures Under Part B

Medicare Part B covers a range of interventional pain management procedures when performed by a qualified physician (anesthesiologist, physiatrist, pain management specialist, orthopedic surgeon, or neurosurgeon):

Epidural Steroid Injections

Lumbar, cervical, and thoracic epidural steroid injections (ESI) deliver corticosteroids into the epidural space to reduce inflammation around compressed nerve roots. They are among the most commonly performed pain procedures under Medicare:

• Covered under Part B (physician service and facility fee separately billed)
• 80/20 cost-sharing after deductible
• Medicare typically covers up to 3–4 injections per region per year, though frequency limits are not fixed by policy — the physician must document medical necessity for each injection
• Approaches covered: interlaminar epidural, transforaminal epidural (selective nerve root block), caudal epidural

Facet Joint Injections and Medial Branch Blocks

Facet joint pain from arthritis in the small joints of the spine is extremely common in Medicare-aged patients. Medicare covers:

• Facet joint injections (intra-articular): covered under Part B
• Medial branch blocks (diagnostic blocks to confirm facet origin of pain): covered under Part B; typically two diagnostic blocks required before radiofrequency ablation is approved
• Radiofrequency ablation (RFA) of medial branch nerves: the definitive treatment for facet pain, covered under Part B; provides 6–18 months of relief; can be repeated when pain returns

Sacroiliac Joint Injections

Sacroiliac joint dysfunction causes low back and buttock pain and is particularly common in older adults. Medicare covers:

• Sacroiliac joint injections: covered under Part B
• Cooled radiofrequency ablation of lateral branch nerves: covered under Part B for confirmed SI joint pain

Trigger Point Injections

Trigger point injections (TPIs) with local anesthetic (and sometimes corticosteroid) treat myofascial pain — muscular knots that cause local and referred pain. Medicare covers TPIs under Part B, typically with a limit of 3 injections per trigger point per year under Medicare guidelines.

Joint Injections for Arthritis

Intra-articular injections for osteoarthritis pain are covered under Part B:

• Corticosteroid injections into knees, hips, shoulders, and other joints: covered at 80/20
• Hyaluronic acid (viscosupplementation) injections (Euflexxa, Supartz, Gel-One, Synvisc): Medicare covers these for knee osteoarthritis under Part B, though some Medicare Advantage plans restrict coverage or require prior authorization

Nerve Blocks for Neuropathic Pain

• Celiac plexus block: covered under Part B for abdominal pain from pancreatic cancer or chronic pancreatitis
• Stellate ganglion block: covered for sympathetically-mediated pain conditions
• Intercostal nerve blocks: covered for post-herpetic neuralgia (shingles pain) and post-thoracotomy pain
• Peripheral nerve blocks: covered when performed for chronic pain indications

Opioid Medications Under Medicare Part D

For patients with severe chronic pain not adequately managed by other means, opioid analgesics are covered under Medicare Part D. However, Medicare Part D has specific policies governing opioid prescriptions that every beneficiary should understand.

Opioid Safety Policies in Part D

The Opioid Morphine Milligram Equivalent (MME) Policies implemented by CMS require Part D plans to use drug utilization review (DUR) programs that flag potentially unsafe opioid prescribing:

• MME thresholds: Plans must review prescriptions for beneficiaries receiving a cumulative daily dose exceeding 90 MME (morphine milligram equivalents). This is a safety review trigger, not a hard coverage cutoff — but it typically triggers a prior authorization requirement
• Concurrent opioid and benzodiazepine prescriptions: Plans are required to screen for concurrent opioid and benzodiazepine prescriptions, as this combination carries elevated overdose risk. Concurrent use triggers enhanced review

Prior Authorization for High-Dose Opioids

Most Part D plans require prior authorization for:

• Opioid prescriptions that would result in cumulative daily doses exceeding 90 MME
• Long-acting or extended-release opioids (ER/LA opioids): OxyContin, MS Contin, fentanyl patches, Exalgo, Hysingla
• High daily doses of short-acting opioids
• Certain high-risk opioid formulations

Prior authorization requires the prescribing physician to document: the specific diagnosis causing pain, prior treatments tried and failed, current pain management plan, and that the benefits outweigh the risks at the prescribed dose. Pain management specialists and patients with well-documented chronic pain conditions typically succeed in getting prior authorization approved.

Commonly Covered Opioid Medications

Under the $2,000 Part D out-of-pocket cap (2025), opioid costs are capped annually along with all other Part D drugs.

Non-Opioid Prescription Analgesics Under Part D

Many effective non-opioid pain medications are covered under Part D:

• Gabapentin and pregabalin (Lyrica): widely used for neuropathic pain; gabapentin generic is Tier 1–2 at very low cost; pregabalin brand Lyrica is typically higher tier
• Duloxetine (Cymbalta): FDA-approved for diabetic neuropathy, fibromyalgia, musculoskeletal pain; generic is low cost
• Tricyclic antidepressants (amitriptyline, nortriptyline): generic; very low cost; effective for neuropathic pain
• Topical diclofenac (Voltaren Arthritis Pain OTC, Pennsaid Rx): Part D covers prescription topical NSAIDs; OTC versions not covered
• Lidocaine patches (Lidoderm): covered under Part D for post-herpetic neuralgia and other localized pain

Spinal Cord Stimulation

Spinal cord stimulation (SCS) is a well-established, evidence-based treatment for chronic intractable spinal pain, complex regional pain syndrome, and failed back surgery syndrome. Medicare covers SCS under Part B:

Trial period: A temporary SCS lead is placed percutaneously and connected to an external stimulator for 3–7 days. If pain is reduced by 50% or more, the trial is considered successful. Medicare covers the trial procedure under Part B.

Permanent implant: Following a successful trial, the permanent SCS system (implantable pulse generator and leads) is surgically implanted. Medicare covers the implant procedure under Part B. The device itself is included in the Part B payment.

Coverage requirements: Medicare requires documentation that:

• Pain has been present for at least 3 months
• Conventional therapies (PT, medications, prior surgeries) have been tried and failed
• A psychological evaluation confirms the patient is appropriate for implant (mental health clearance)
• No active untreated infection or coagulopathy

SCS is a major procedure with inpatient or outpatient surgical facility involvement. For an outpatient procedure, the patient pays 20% of the facility fee plus 20% of the surgeon fee after the Part B deductible. Without Medigap, this can represent several thousand dollars. With Medigap Plan G, coinsurance is fully covered.

Peripheral Nerve Stimulation

Peripheral nerve stimulation (PNS) devices for specific nerve distributions are increasingly covered under Part B as evidence accumulates. Coverage varies by Medicare contractor; check with the ordering physician whether prior authorization is required.

TENS Units Under Part B as DME

Transcutaneous electrical nerve stimulation (TENS) units are battery-powered devices that deliver low-voltage electrical current to the skin to reduce pain. Medicare covers TENS units under Part B as durable medical equipment (DME) — but with a narrow indication:

Medicare covers TENS only for chronic low back pain in beneficiaries who have had chronic back pain for at least 3 months and who have tried other conservative treatments. TENS for other pain conditions (neck pain, fibromyalgia, arthritis in other joints) is generally not covered under Medicare.

If covered: standard Part B DME cost-sharing applies (20% after deductible, then ownership after a rental period).

Pain Psychology and Behavioral Health Under Part B

Psychological approaches to pain — cognitive behavioral therapy (CBT) for pain, acceptance and commitment therapy (ACT), mindfulness-based stress reduction — are evidence-based treatments that reduce pain intensity and improve function. Medicare covers pain psychology under Part B mental health benefits:

• Individual psychotherapy with a licensed psychologist or clinical social worker: covered under Part B at 80/20 cost-sharing
• Cognitive behavioral therapy for chronic pain: covered as individual psychotherapy
• Behavioral health integration services: when a primary care physician coordinates behavioral health treatment for chronic pain as part of a chronic care management model, additional care management codes are covered under Part B

Note: Medicare Part B mental health coinsurance was historically 50% (unlike the standard 20% for medical services), but this was equalized to 20% in 2014. Mental health services and medical pain management are now at the same 20% coinsurance under Part B.

Comprehensive Pain Management Programs

Interdisciplinary pain management programs (IPMPs) — combining physician management, physical therapy, pain psychology, occupational therapy, and vocational rehabilitation in a structured program — are the gold standard of care for refractory chronic pain. Medicare covers IPMPs under Part B, but coverage is limited to programs that:

• Are administered by a physician
• Operate in a Medicare-approved outpatient setting (hospital outpatient department or clinic)
• Document medical necessity for the comprehensive interdisciplinary approach

Not all IPMPs are Medicare-enrolled. If your physician recommends an IPMP, verify Medicare enrollment before beginning.

Chronic Care Management for Pain Patients

Beneficiaries with two or more chronic conditions — which includes virtually every chronic pain patient with comorbid arthritis, diabetes, or cardiovascular disease — are eligible for Chronic Care Management (CCM) services under Part B. CCM is billed by the primary care physician for at least 20 minutes per month of non-face-to-face care coordination:

• Annual CCM billing generates 20% coinsurance for the patient (covered by Medigap)
• The care coordination includes medication management, specialist communication, and care plan development — all relevant to chronic pain management

Planning for Chronic Pain Costs Under Medicare

Chronic pain management can generate substantial Part B costs through ongoing physical therapy, interventional procedures, and specialist visits. Understanding cost-sharing at the time of coverage enrollment helps avoid surprises:

Medigap Plan G is the best financial protection for heavy users of Part B services. It covers the Part B deductible and all Part B coinsurance — meaning physical therapy, injections, SCS procedures, and pain psychology are all covered after the one-time $257 annual deductible.

Medicare Advantage plans may have lower monthly premiums but impose prior authorization requirements on pain procedures. Epidural steroid injections, facet joint radiofrequency ablation, and SCS often require prior authorization. Delays in approval can affect pain management continuity. Review your MA plan’s prior authorization requirements for interventional pain procedures before committing to that coverage.

Part D plan selection matters for patients on opioid or neuropathic pain medications. Check your specific medications against each plan’s formulary using the Medicare Plan Finder at Medicare.gov. Formulary tiers and step therapy requirements for pain medications vary significantly across plans.

For beneficiaries managing related conditions, see our guides on Medicare back pain and spinal care coverage for the specific coverage of spinal procedures, and Medicare coverage for mental health for the full behavioral health benefit. The Medicare Part D explained guide covers the $2,000 out-of-pocket cap and Extra Help program for beneficiaries managing multiple pain medications. For musculoskeletal disease management, Medicare joint replacement surgery covers the Part A and SNF coverage that often follows major orthopedic procedures for arthritis and pain.